Clinical Trials on Hormone Receptor Negative Neoplasm in Russian Federation
Total 184 results
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
Russian Academy of Medical SciencesCompletedInduction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerTriple Negative Breast CancerRussian Federation
-
National Research Center for Hematology, RussiaUnknownPh-negative Adult Acute Lymphoblastic LeukemiaRussian Federation
-
Saint Petersburg State University, RussiaCompletedAnesthesia | Parathyroid Neoplasms | Thyroid NeoplasmRussian Federation
-
Moscow Clinical Scientific CenterRecruitingGastric Cancer | Helicobacter Pylori Infection | Gastric AtrophyRussian Federation
-
Yaroslavl State Medical AcademyTerminatedThyroid NodulesRussian Federation
-
Russian Academy of Medical SciencesUnknownOvarian CancerRussian Federation
-
St. Petersburg State Pavlov Medical UniversityTerminatedMyelodysplastic Syndromes | Leukemia, Chronic Myeloid | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeRussian Federation
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...UnknownSarcoma | Neoplasms, Connective and Soft TissueRussian Federation
-
Blokhin's Russian Cancer Research CenterUnknownOvarian Neoplasms | Ovarian Cancer | Chemotherapy | BRCA1 Mutation | BRCA2 Mutation | Serous AdenocarcinomaRussian Federation
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Saint Petersburg State University, RussiaWithdrawnThyroid Gland Anaplastic CarcinomaRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; The Shemyakin and Ovchinnikov Institute of Bioorganic ChemistryEnrolling by invitationOvarian Cancer | Lung CancerRussian Federation
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Pancreas CancerRussian Federation
-
Saint Petersburg State University, RussiaWithdrawnPoorly Differentiated Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma by AJCC V8 StageRussian Federation
-
State Budget Public Health Institution Scientific...Active, not recruitingPancreatic Cancer | Bile Duct Cancer | Ampulla of Vater CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingMelanoma | Lung Cancer | Pancreas Cancer | Refractory Cancer | Colorectal Cancer Recurrent | RAS Mutation | Ras (Kras or Nras) Gene MutationRussian Federation
-
Tomsk National Research Medical Center of the Russian...CompletedBreast Cancer | Ovarian Cancer | Endometrial CancerRussian Federation
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Endocrinology Research Centre, MoscowRussian Science FoundationCompletedDiabetes Mellitus, Type 1 | Primary Hyperparathyroidism | Acromegaly | Pituitary ACTH HypersecretionRussian Federation
-
Moscow City Oncology Hospital No. 62CompletedEndometrial Neoplasms | Endometrial Cancer | Sentinel Lymph Node | Endometrial Endometrioid Adenocarcinoma | Endometrial Adenocarcinoma | Hysterectomy | Endometrial Cancer Stage I | Laparoscopic Hysterectomy | Endometrial Cancer Stage IIRussian Federation
-
NewVac LLCJanssen Pharmaceutica N.V., BelgiumCompletedOvarian CancerRussian Federation
-
Tyumen State Medical AcademyUnknownHyperandrogenism | Polycystic Ovarian Syndrome | Menstrual IrregularitiesRussian Federation
-
Poniard PharmaceuticalsUnknownHormone Refractory Prostate CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingOvarian CancerRussian Federation
-
NewVac LLCJanssen Pharmaceutica N.V., BelgiumCompletedEpithelial Ovarian Cancer | Non-small Cell Lung CancerRussian Federation
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Saint Petersburg State University, RussiaCompletedHypocalcemia | Secondary Hyperparathyroidism | Dialysis | Hypoparathyroidism | Chronic Kidney Disease-Mineral and Bone DisorderRussian Federation
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Saint Petersburg State University, RussiaCompletedSecondary Hyperparathyroidism | Dialysis | Vascular Calcification | Chronic Kidney Disease Mineral and Bone DisorderRussian Federation
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Moscow Clinical Scientific CenterIRCCS San Raffaele; Istanbul University; University of Belgrade; University of... and other collaboratorsUnknownPancreatic Cancer | Malnutrition | Chemotherapy | Exocrine Pancreatic Insufficiency | Metastatic Pancreatic Cancer | Locally Advanced Malignant NeoplasmTurkey, Italy, Romania, Russian Federation, Serbia, Spain
-
AB ScienceCompletedOvarian CancerFrance, United Kingdom, Ukraine, Algeria, Russian Federation, Spain
-
Eisai Inc.CompletedThyroid CancerUnited States, France, Ukraine, Peru, Russian Federation, Argentina
-
Eli Lilly and CompanyCompletedFallopian Tube Neoplasms | Ovarian Cancer | Peritoneal NeoplasmSpain, Poland, Belgium, Russian Federation, Germany
-
OMRIX BiopharmaceuticalsSuspendedOvarian Cysts | Endometriosis | AdhesionsSpain, United States, Mexico, Russian Federation, Germany
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
AB ScienceCompletedLocally Advanced or Metastatic Pancreatic CancerFrance, Belgium, Greece, India, Russian Federation, Slovakia, Tunisia, Ukraine
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerItaly, United States, Russian Federation
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
BayerRegeneron PharmaceuticalsCompletedMacular EdemaGermany, Italy, Russian Federation, Taiwan, China, Egypt, France, Kuwait, Lebanon, Saudi Arabia, United Arab Emirates
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom